Intestinal microbiota: the invisible army in cancer treatment
The article discusses the role of gut microbiota in cancer treatment, particularly in immunotherapy, highlighting its significance in training the immune system.
Reinforced immune cells with a 'bait' manage to better catch cancer
Research has developed stronger, longer-lasting, and more precise T lymphocytes against prostate tumors, leading to the potential for more powerful immunotherapies.
How One of the Blood Cancers with the Worst Prognosis Managed to Extend Survival to Over 15 Years
Recent advances in immunotherapy and personalized medicine have significantly improved the survival rates of multiple myeloma patients, extending life expectancy to over 15 years.
The thymus: the key piece of aging and cancer that science ignored for decades
Two new studies suggest that the thymus plays a critical role in adult health, including longevity and cancer response, challenging long-held beliefs about its irrelevance in adulthood.
Intestinal bacteria influence the effectiveness of immunotherapy in cancer, studies show
Recent studies indicate that intestinal bacteria significantly affect the efficacy of cancer immunotherapy treatments.
Health plan suspends medication for elderly woman with cancer for the second time in less than a year
A 74-year-old woman is struggling to continue her lung cancer treatment after her health plan suspended her immunotherapy medication, prompting her family to seek legal assistance.
Senate approves project to accelerate immunotherapy against cancer in SUS; see how the treatment that revolutionized oncology works
Brazil's Senate has approved a bill to expedite access to immunotherapy for cancer patients under the public health system, SUS, pending presidential approval.
He reacts to the common reed. And is allergic to at least 16 other things
Mathias Herup, a 26-year-old from Denmark, recently discovered he is allergic to at least 16 substances, including common reed pollen, and is hopeful about new broad-spectrum immunotherapy research that could treat multiple allergies simultaneously.
CAR-T Therapy Advances in Brazil with Research to Reduce Costs and Reach the SUS
Brazil is advancing CAR-T therapy, a revolutionary cancer treatment, with research aimed at reducing production costs for public health access.
Promising results for the treatment of deadly brain tumor
Researchers may have found a method to treat aggressive brain tumors, with a new treatment showing significantly improved survival rates compared to standard care.
Development of a method to personalize immunotherapy in lung cancer
A research team in Málaga has created a method for personalizing lung cancer immunotherapy through blood analysis, identifying molecular subtypes that predict survival.
Hope for colorectal cancer patients as Nigeria begins immunotherapy trial
Nigeria has initiated immunotherapy trials aimed at providing promising treatment options for colorectal cancer patients.
Michel Sadelain, one of the fathers of CAR-T, the promising therapies against cancer: "They are living medications that multiply within the patient's body"
Michel Sadelain, a key figure in CAR-T therapy, discusses the advancements in cancer treatment and the ongoing challenges in targeting solid tumors.
Trained defenses attack the 'castle' of solid tumors: CAR-T therapies find weaknesses in the kidney, ovary, and pancreas
Recent advances in CAR-T therapy show potential for effectively targeting solid tumors in organs such as the kidney, ovary, and pancreas, addressing a significant challenge in cancer treatment.
If outpatient treatment exceeds 300 times a year, the cost responsibility rate will rise to 90%... Immunotherapy for bile duct cancer included in health insurance
A new plan in South Korea proposes increasing the personal cost responsibility rate for outpatient treatments exceeding 300 visits annually to 90%, while also expanding health insurance coverage for immunotherapies for bile duct cancer.
Initial success of a personalized vaccine against triple-negative breast cancer, the most aggressive
A clinical trial shows promising results for a personalized vaccine targeting triple-negative breast cancer, with hopes for approval within four years.
Injectable immunotherapies: how the new cancer treatments already being used in the country work
Argentina is embracing a new trend in cancer treatment with injectable immunotherapies, recently approved to provide a more convenient alternative to traditional intravenous chemotherapy.
Hockey players raise funds to expand CAR T-cell therapy access in Edmonton
Hockey players at the World’s Longest Hockey Game are fundraising to support CAR T-cell therapy access at Edmonton's Cross Cancer Institute.
The scientists who have revolutionized treatment for different types of blood cancer win the Fronteras prize
American oncologist Carl June and French geneticist Michel Sadelain have been awarded the BBVA Foundation's Fronteras del Conocimiento Prize for their innovative CAR-T cell therapy for blood cancers.
The parents of CAR T therapies against cancer receive the BBVA Foundation Frontiers of Knowledge Award in Biomedicine
Researchers Carl June and Michel Sadelain have been awarded the BBVA Foundation Frontiers of Knowledge Award in Biomedicine for their pioneering work in CAR-T cell therapies that transform cancer treatment.
International research involving Greece proposes innovative treatment for hematological cancers
An international research initiative including Greek scientists proposes a novel immunotherapy treatment for blood cancers using modified CAR-T cells.
Cancer: Argentina approves an immunotherapy for solid tumors that is administered through injections
Argentina's ANMAT has approved a new anti-PD-1 immunotherapy that can be administered via injections in three to five minutes, maintaining the efficacy of intravenous delivery.
OAUTH unveils Nigeria’s first immunotherapy trial for colorectal cancer
The Obafemi Awolowo University Teaching Hospital has launched Nigeria's first clinical trial for colorectal cancer treatment, offering free treatments in partnership with major hospitals.
Researchers target tumor protection function with new immunotherapy
A research team from the USA has developed a new immunotherapy that removes a previously overlooked protective mechanism of tumors, showing promising results, though so far only in the lab.